The global pharmaceutical industry experienced a 21% rise in new job postings related to artificial intelligence in Q2 2023 compared with the previous quarter, according to GlobalData’s Job Analytics. This compares to a 15% increase versus Q2 2022. Artificial Intelligence is among the top emerging technologies being employed for drug discovery and development and has demonstrated strong potential in the Pharmaceutical sector. GlobalData’s Artificial Intelligence (AI) in Drug Discovery Market – Thematic Research report provides a detailed understanding of key trends, industry analysis, AI specialists in drug discovery. Buy the report here.
Smarter leaders trust GlobalData
Notably, Management Occupations jobs accounted for a 21% share of the global pharmaceutical industry’s artificial intelligence-related total new job postings in Q2 2023, down 7% over the prior quarter.
Management Occupations drive artificial intelligence-related hiring activity
Management Occupations, with a share of 21%, emerged as the top artificial intelligence-related job roles within the pharmaceutical industry in Q2 2023, with new job postings drop by 7% quarter-on-quarter. Computer and Mathematical Occupations came in second with a share of 19% in Q2 2023, with new job postings dropping by 11% over the previous quarter.
The other prominent artificial intelligence roles include Life, Physical, and Social Science Occupations with an 8% share in Q2 2023, Business and Financial Operations Occupations with a 2% share of new job postings.
Top five companies in pharmaceutical industry accounted for 52% of hiring activity
The top companies, in terms of number of new job postings tracked by GlobalData, as of Q2 2023 were Johnson & Johnson, Novo Nordisk, Novartis, Bristol-Myers Squibb, and Merck. Together they accounted for a combined share of 52% of all artificial intelligence-related new jobs in the pharmaceutical industry.
Johnson & Johnson posted 1,417 artificial intelligence-related new jobs in Q2 2023, Novo Nordisk 327 jobs, Novartis 315 jobs, Bristol-Myers Squibb 214 jobs, and Merck 209 jobs, according to GlobalData’s Job Analytics.
Hiring activity was driven by the US with a 44.75% share of total new job postings, Q2 2023
The largest share of artificial intelligence-related new job postings in the pharmaceutical industry in Q2 2023 was in the US with 44.75% followed by India (10.94%) and Denmark (4.30%). The share represented by the US was 15 percentage points lower than the 59.65% share it accounted for in Q1 2023.
For further understanding of GlobalData's Artificial Intelligence (AI) in Drug Discovery Market - Thematic Research, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Jobs Analytics uses machine learning to uncover key insights from tracking daily job postings for thousands of companies globally. Proprietary analysis is used to group jobs into key thematic areas and granular sectors across the world’s largest industries. classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
